141 related articles for article (PubMed ID: 2070683)
1. Role of TGF-beta 1 in experimental glomerulonephritis.
Border WA; Okuda S; Nakamura T; Languino LR; Ruoslahti E
Ciba Found Symp; 1991; 157():178-89; discussion 189-93. PubMed ID: 2070683
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
Border WA; Ruoslahti E
Cell Differ Dev; 1990 Dec; 32(3):425-31. PubMed ID: 2099240
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
Okuda S; Languino LR; Ruoslahti E; Border WA
J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
[TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.
Border WA; Okuda S; Languino LR; Sporn MB; Ruoslahti E
Nature; 1990 Jul; 346(6282):371-4. PubMed ID: 2374609
[TBL] [Abstract][Full Text] [Related]
5. The effect of transforming growth factor beta 1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing.
McKay NG; Khong TF; Haites NE; Power DA
Exp Mol Pathol; 1993 Dec; 59(3):211-24. PubMed ID: 8137903
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Huijun W; Long C; Zhigang Z; Feng J; Muyi G
Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
8. [Role of TGF-beta in glomerular diseases].
Okuda S
Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
[TBL] [Abstract][Full Text] [Related]
9. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.
Kagami S; Border WA; Ruoslahti E; Noble NA
Lab Invest; 1993 Jul; 69(1):68-76. PubMed ID: 8331901
[TBL] [Abstract][Full Text] [Related]
10. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
Border WA; Noble NA; Yamamoto T; Harper JR; Yamaguchi Yu; Pierschbacher MD; Ruoslahti E
Nature; 1992 Nov; 360(6402):361-4. PubMed ID: 1280332
[TBL] [Abstract][Full Text] [Related]
11. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta.
López-Armada MJ; Gómez-Guerrero C; Egido J
J Immunol; 1996 Sep; 157(5):2136-42. PubMed ID: 8757338
[TBL] [Abstract][Full Text] [Related]
12. In vivo transfer of engineered macrophages into the glomerulus: endogenous TGF-beta-mediated defense against macrophage-induced glomerular cell activation.
Sütö TS; Fine LG; Shimizu F; Kitamura M
J Immunol; 1997 Sep; 159(5):2476-83. PubMed ID: 9278341
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .
Kitamura M; Sütö T; Yokoo T; Shimizu F; Fine LG
J Immunol; 1996 Apr; 156(8):2964-71. PubMed ID: 8609417
[TBL] [Abstract][Full Text] [Related]
14. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta (TGF-beta) stimulates the expression of beta1 integrins and adhesion by rat mesangial cells.
Kagami S; Kuhara T; Yasutomo K; Okada K; Löster K; Reutter W; Kuroda Y
Exp Cell Res; 1996 Nov; 229(1):1-6. PubMed ID: 8940242
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta and the pathogenesis of glomerular diseases.
Border WA
Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):54-8. PubMed ID: 7850412
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
Daniel C; Wagner A; Hohenstein B; Hugo C
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S
Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
[TBL] [Abstract][Full Text] [Related]
19. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
Gaedeke J; Boehler T; Budde K; Neumayer HH; Peters H
Nephrol Dial Transplant; 2005 Feb; 20(2):319-28. PubMed ID: 15673690
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta.
Zhu L; Herrera GA; Murphy-Ullrich JE; Huang ZQ; Sanders PW
Am J Pathol; 1995 Aug; 147(2):375-85. PubMed ID: 7639331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
